We're in the middle of another big week for earnings, with a slew of medical-related companies among those reporting. Regeneron hit a new high in the stock market today after issuing better-than-expected Q2 earnings. The biotech also raised its growth forecast for its blockbuster Eylea drug. Shares gapped up in big volume, hitting a fresh high and clearing the 600 price... More